Novelos Therapeutics Announces Presentation of Positive Phase 2 Results in NOV-002 Neoadjuvant Breast Cancer Trial at San Antonio Breast Cancer Symposium Business Wire “Press Releases – English” Recent Share Exchange Expected to Facilitate Expansion of Novelos Oncology Pipeline NEWTON, Mass. –(BUSINESS WIRE)– Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company developing therapeutics to treat cancer, announced […]
Day-Trading Penny Stocks